Index
- WelbeHealth Becomes First Program of All-Inclusive Care for the Elderly (PACE) Provider to Convert to Public Benefit Company Status
- Kyruus Announces Paul Merrild as Company’s First President
- Protenus is Top-Performing Solution in KLAS Drug Diversion Monitoring 2022 Report
- Snapdocs and STRATMOR Group Collaborate to Advance Borrower Experience Research
- Equip Publishes Study Showing Virtual Treatment is Highly Effective for Eating Disorders as Company Expands to 50 States
- Sondermind -The Company Redesigning Behavioral Health For Patients And Therapists
- Immuneel Therapeutics raises $15 million in funding
- Insilico Medicine appoints Dr. Feng Ren as co-CEO
- Xilio Therapeutics Announces Promotion of Martin Huber, M.D., to President
- Vendr Raises $150MM Series B to Help CFOs Reduce Software Expense
- As their first clinical data test looms, global AI player Insilico bumps up a GSK vet to co-CEO in charge of development
- Has Denali found a way to correct gene mutations linked to Parkinson’s? Possibly, but questions remain
- PROXIMIE RAISES $80 MILLION IN SERIES C FUNDING TO ACCELERATE PRODUCT EXPANSION OF FULL-SERVICE CONNECTED SURGICAL PLATFORM
- Singular Genomics and Olink collaborate to enable Olink® Explore on the G4 Max Read™ sequencing kits
- Big names, big backers: David Baker joins OrbiMed, F-Prime, Khosla and others as protein-ligand biotech launches
- Exclusive: Medical AI startup Owkin just secured $80 million as it gears up to enhance drug trials with the pharmaceutical giant Bristol Myers Squibb
- Singular Genomics and Olink collaborate to enable Olink® Explore on the G4 Max Read™ sequencing kits
- Ontrak Health and Eleos Announce AI Integration Partnership to Support Care for Ontrak Members
- Insilico Medicine Raises $60 Million in Series D Financing to Advance Pipeline and Launch AI-powered Drug Discovery Robotics Laboratory
- MediKarma Selects 1upHealth as its Interoperability Partner to Help Patients Acquire Their Medical Records from Hospital EMRs
- Innovent and IASO Bio Jointly Announce the NMPA Acceptance of the New Drug Application for Equecabtagene Autoleucel for the Treatment of Relapsed and/or Refractory Multiple Myeloma
- Sana Biotechnology ditches California manufacturing plans in bid to save $100M
- Sana Biotechnology ditches California manufacturing plans in bid to save $100M
- 1upHealth Selected by NCQA As Partner in Digital Quality Solutions Pilot
- SpectrumAi, an LA startup centered on autism, raised $9M in seed funding
- Denali Therapeutics and Biogen Announce Initiation of Phase 2b Study of LRRK2 Inhibitor in Parkinson’s Disease
- Apotea Deploys RightPick™ 3 Item-Handling System from RightHand Robotics™ to Expedite Operations for Consumers
- Insilico Medicine Announces Novel 3CL Protease Inhibitor Preclinical Candidate for COVID-19 Treatment
- Cytek® Biosciences Receives CE Marking for Series of cFluor® Reagents, TBNK Kit
- Lenders One® Adds Snapdocs as a Preferred eClosing Provider
- WellAir Brings Clean Air Technology to Brandywine Realty Trust Properties
- Xilio Therapeutics Appoints Stacey Davis as Chief Business Officer
- AppliedVR Partners with Kernel to Measure Brain Activity Changes Before, During, and After Virtual Reality (VR) Treatment of Chronic Pain
- Coherus BioSciences Appoints Dr. Jill O’Donnell-Tormey to its Board of Directors
- Sana Biotechnology Congratulates Senior Vice President and Head of T Cell Therapeutics, Terry Fry, M.D., on Additional Role at the University of Colorado’s Gates Institute
- NodThera Announces Clinical Progress for Lead NLRP3 Inflammasome Inhibitors and Candidate Selection of Novel Brain-Penetrant Compound
- Singular Genomics Announces Formation of Scientific Advisory Board
- Verve Therapeutics Announces Clearance of First VERVE-101 Clinical Trial Application and Outlines Global Clinical Development Strategy; Reports First Quarter 2022 Financial Results
- Rallybio wades into Sanofi storeroom for $3M rare disease deal
- Invetx raises $60.5 million to make long-lasting antibody therapies for cats and dogs
- Verve Therapeutics Reports Additional VERVE-101 and GalNAc-Lipid Nanoparticle Delivery Data in Non-Human Primates at TIDES USA 2022
- How cell & gene therapy startups can warm up to investors in this “biotech nuclear winter”
- Insilico Medicine expands synthetic lethality portfolio with nomination of a preclinical candidate targeting MAT2A for the treatment of MTAP-deleted cancers
- Denali Therapeutics Announces Achievement of RIPK1 Milestone for Phase 2 Clinical Trial Initiation in ALS by Sanofi
- AppliedVR taps Komodo Health to prove out its VR therapeutic for chronic pain
- WellAir Announces Kari Dixon as President and Chief Executive Officer
- Wellframe Addresses the Caregiver Crises Through an Expanded Program Aimed to Assist 250,000 Members by 2025
- Cytek Biosciences Appoints Todd Garland Chief Commercial Officer
- These fast, cheap tests could help us coexist with covid
- 1upHealth Announces SQL on FHIR® to Easily Ask Hard Questions of Healthcare FHIR® Data and Make Timely Real-World Decisions
- Zolgensma for dementia? AviadoBio gains orphan tag for one-dose gene therapy
- ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors
- MedCity Pivot Podcast: A conversation with Buoy Health’s chief medical officer
- Artemis Health Launches New Solution to Improve Evaluation and Optimization of Point Solutions
- Eleos Health and Zero Suicide Institute Join Forces to Incorporate Best Practices for Suicide Prevention Into Eleos’ Platform
- Turnstone Biologics Announces Executive Leadership Appointments
- Protenus Granted New Patent ‘Methods and Systems for Analyzing Accessing of Drug Dispensing Systems’
- Regeneron to Acquire Checkmate Pharmaceuticals and Its Investigational Immune Activator for Potential Use in Multiple Tumor Types
- Whatfix Acquires Leap.is to Expand Mobile Capabilities
- OTA Insight Acquires Kriya RevGEN, Adding Market-Leading Hotel Portfolio & Chain Revenue Intelligence Solution To Commercial Platform
- Innovent Receives NMPA Breakthrough Designation for IBI310, the Anti-CTLA-4 Monoclonal Antibody, Combined with Sintilimab in Advanced Cervical Cancer Treatment
- Insilico Medicine Announces Advancement of Its Preclinical Candidate for USP1 Synthetic Lethality Target to IND-enabling Studies for Various Oncological Disorders
- Orchard Therapeutics Announces Reimbursement Agreement Making Libmeldy Available for All Eligible MLD Patients in Italy
- PROOF DIAGNOSTICS SUBMITS REQUEST FOR EMERGENCY USE AUTHORIZATION SEEKING FIRST APPROVAL OF CRISPR-BASED MOLECULAR POINT-OF-CARE COVID-19 TEST
- Innovent Announces the Approval of Pemazyre® (pemigatinib) by the NMPA for the Treatment of Adults with Locally Advanced or Metastatic Cholangiocarcinoma with A FGFR2 Fusion or Rearrangement As Confirmed By A Validated Diagnostic Test That Have Progressed After at Least One Prior Line of Systemic Therapy
- Doceree Closes $11 Million Series A Funding Round Led by F-Prime Capital
- Eleos Health Raises $20M to Unlock In-Session Behavioral Health Voice Data
- Kyruus Welcomes Gail Airasian as General Manager of Emerging Markets as the Company Expands Its Platform to Serve the Broader Digital Health Market
- TraceLink Announces Product Availability Intelligence, Enabling Manufacturers to Predict Drug Shortages up to 90 Days in Advance with Greater Than 80% Accuracy
- HealthTap Joins Buoy Health’s Navigation Initiative to Match More People with the Right Health Care
- Rallybio Appoints Christine A. Nash and Hui Liu, Ph.D., to Its Board of Directors
- Ivenix to be Acquired by Fresenius Kabi
- Insilico Medicine Announces Strategic Collaboration with EQRx to Jointly Advance AI-driven Drug Discovery, Development and Commercialization for Multiple Targets
- AmplifyMD Raises $23 Million to Improve Patient Access to Specialty Care
- Innovent and Lilly Expand Strategic Partnership in Oncology
- WellAir Launches a New Advanced Air Cleaning Device in Europe with Independently Tested Industry Leading 99.9% Effectiveness Against Airborne Pathogens
- AppliedVR Renames Its FDA-approved Virtual Reality Therapeutic ‘RelieVRx’ and Announces Three-month Durability Study Results
- Aerium Therapeutics launches to develop novel therapeutics against COVID-19 and future pandemic threats
- Carrot Fertility rolls out age-inclusive benefits for menopause, low testosterone
- Notabene partners with global sanctions screening leader Refinitiv to deliver seamless counterparty sanction screening
- WellHive Announces Partnership with Kyruus to Integrate Systems and Optimize Care Navigation for Veterans
- Equip and Magellan Healthcare Collaborate to Offer Virtual Eating Disorder Treatment in California
- Atalanta Therapeutics Appoints Alfred Sandrock to Board of Directors
- UPMC and Kyruus Launch Strategic Partnership to Transform Digital Patient Access and Care Navigation
- Silq spins its technology into visibility for apparel manufacturing
- Flywire and Tribal Group Partner to Deliver Integrated Payments Solution for Education Market
- Proximie Selected As A Featured Innovator at LSI 2022 Medtech Investor Summit
- Owkin welcomes leading immuno-oncology professor as Chief Medical Officer and senior pharma exec as SVP Data Science
- Rialtic Completes Series A Extension Bringing Total Round to $45 Million
- Insilico Announces Successful Completion of Phase 0 Microdose Trial and Initiates Phase I Clinical Trial for its First AI-discovered Anti-fibrotic Product Candidate with Novel Target